Adoptive Cellular Immunotherapy | List of Frontiers open access articles

Review

Published on 22 Dec 2017

Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications

in Cancer Immunity and Immunotherapy

Hamid R. Mirzaei
Analiz Rodriguez
Jennifer Shepphird
Christine E. Brown
Behnam Badie

Frontiers in Immunology

doi 10.3389/fimmu.2017.01850

30,677 views
207 citations

Review

Published on 19 Apr 2022

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

in Cancer Immunity and Immunotherapy

Amin Daei Sorkhabi
Aila Sarkesh
Hossein Saeedi
Faroogh Marofi
Mahnaz Ghaebi
Nicola Silvestris
Behzad Baradaran
Oronzo Brunetti

Frontiers in Oncology

doi 10.3389/fonc.2022.818447

5,931 views
17 citations

Review

Published on 08 Jan 2021

Allogeneic CAR Cell Therapy—More Than a Pipe Dream

in Alloimmunity and Transplantation

Kenneth J. Caldwell
Stephen Gottschalk
Aimee C. Talleur

Frontiers in Immunology

doi 10.3389/fimmu.2020.618427

40,678 views
124 citations

Review

Published on 22 Dec 2020

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

in Hematologic Malignancies

Scott R. Goldsmith
Armin Ghobadi
John F. DiPersio

Frontiers in Oncology

doi 10.3389/fonc.2020.608916

12,515 views
18 citations

Original Research

Published on 09 Jun 2025

Adoptive cellular immunotherapy combined with chemotherapy versus chemotherapy alone in Chinese patients with metastatic colorectal cancer: a cost-effectiveness analysis to inform drug pricing

in Gastrointestinal Cancers: Colorectal Cancer

Liman Huo
Ping Liang
Yangyang Duan
Yanmei Xu
Jianhua Tang
Qi Lv
Rui Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1590319

2,562 views
1 citation

Review

Published on 21 Aug 2020

Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between “Foe” and “Friend” During Tumor Malignant Transformation

in Cancer Metabolism

Hui Tian
Baofu Zhang
Liantao Li
Gang Wang
Huizhong Li
JunNian Zheng

Frontiers in Oncology

doi 10.3389/fonc.2020.01692

7,371 views
10 citations

Original Research

Published on 06 Jul 2021

HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo

in Virology

Zhengtao Jiang
Huitong Liang
Hanyu Pan
Yue Liang
Hua Wang
Xinyi Yang
Panpan Lu
Xiao Zhang
Jinlong Yang
Dengji Zhang

Frontiers in Microbiology

doi 10.3389/fmicb.2021.684016

8,622 views
28 citations

Review

Published on 11 Jan 2024

Gamma/delta T cells as cellular vehicles for anti-tumor immunity

in Cancer Immunity and Immunotherapy

Chelsia Qiuxia Wang
Pei Yu Lim
Andy Hee-Meng Tan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1282758

12,733 views
27 citations

Review

Published on 28 Nov 2023

DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies

in Cancer Immunity and Immunotherapy

Maria Letizia Giardino Torchia
Gordon Moody

Frontiers in Immunology

doi 10.3389/fimmu.2023.1264882

6,506 views
1 citation

Review

Published on 10 Aug 2021

Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner

in Cancer Immunity and Immunotherapy

Mikel Etxebeste-Mitxeltorena
Inés del Rincón-Loza
Beatriz Martín-Antonio

Frontiers in Immunology

doi 10.3389/fimmu.2021.717850

10,951 views
23 citations

Original Research

Published on 09 Jun 2025

Trained autologous cytotoxic T-cells derived from PBMCs or splenocytes for immunotherapy of neuroblastoma

in Cancer Immunity and Immunotherapy

Xiaofang Wu
Mousumi Basu
Sarah L. Wright
Samuel Li
Mikael Petrosyan
Marie V. Nelson
Alex I. Halpern
Douglas Shea
Mark Yarmakovich
Anthony D. Sandler

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546441

4,362 views

Original Research

Published on 07 Apr 2022

Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies

in NK and Innate Lymphoid Cell Biology

Maren Soldierer
Arthur Bister
Corinna Haist
Aniththa Thivakaran
Sevgi Can Cengiz
Stephanie Sendker
Nina Bartels
Antonia Thomitzek
Denise Smorra
Maryam Hejazi

Frontiers in Immunology

doi 10.3389/fimmu.2022.847008

20,877 views
36 citations

Case Report

Published on 01 Sep 2025

Case Report: Durable complete response to antigen-specific cytotoxic T lymphocyte therapy in advanced EGFR-TKI resistant lung adenocarcinoma: a case of adoptive cellular immunotherapy overcoming acquired targeted resistance

in Cancer Immunity and Immunotherapy

Chenghao Fu
Chengyu Bian
Weiyou Zhu
Haonan Du
Linrui Han
Jian Zhu
Jun Wang
Lei Cao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1637165

3,092 views
2 citations

Articles

Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

Allogeneic CAR Cell Therapy—More Than a Pipe Dream

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

Adoptive cellular immunotherapy combined with chemotherapy versus chemotherapy alone in Chinese patients with metastatic colorectal cancer: a cost-effectiveness analysis to inform drug pricing

Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between “Foe” and “Friend” During Tumor Malignant Transformation

HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo

Gamma/delta T cells as cellular vehicles for anti-tumor immunity

DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies

Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner

Trained autologous cytotoxic T-cells derived from PBMCs or splenocytes for immunotherapy of neuroblastoma

Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies

Case Report: Durable complete response to antigen-specific cytotoxic T lymphocyte therapy in advanced EGFR-TKI resistant lung adenocarcinoma: a case of adoptive cellular immunotherapy overcoming acquired targeted resistance